Safety and efficacy of an extended macular vision intraocular lens (IOL) for age-related macular degeneration (AMD) in real-world settings
The EyeMax Mono intraocular lens (IOL) safely enhances both distant (CDVA) and near (CNVA) visual acuity in patients with age-related macular degeneration, particularly in eyes with intermediate AMD. These findings are consistent with those in the published scientific literature.
Authors
- P. Busatto
- Federico Badalà
- Fritz H. Hengerer
- B. Stanzel
- Jairo Hoyos-Chacón
- Sebastian J. Beckers
- Marta Suarez
Institutions
- University of Trieste (IT)
- Augenklinik Heidelberg (DE)
- Clínica Rementería (ES)
- Knappschaftsklinikum Saar (DE)
- Bürgerhospital Frankfurt am Main (DE)
- Castanera Institute of Ophthalmology (ES)
- Instituto de Microcirugía Ocular (ES)
Publication Details
- Journal
- BMC Ophthalmology
- Published
- 2025-12-23
- DOI
- https://doi.org/10.1186/s12886-025-04515-9
- Primary Topic
- Ophthalmology and Visual Impairment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00